Full Press Release Details
Aurora Cannabis to Begin Trading on the The Nasdaq
Global Select Market on May 25, 2021 at Market Open
EDMONTON, AB, May 24, 2021 /CNW/ - Aurora Cannabis
Inc. (the "Company" or "Aurora") (NASDAQ | TSX: ACB), the Canadian company defining the future of cannabinoids
worldwide, announced that it has completed the transfer of its stock exchange listing to The Nasdaq Global Select Market ("Nasdaq")
from the New York Stock Exchange ("NYSE") after the market close today.
The Company's common stock will begin trading as a
Nasdaq-listed security at market open on May 25, 2021 and will continue to be listed under the ticker symbol "ACB." This transition
does not impact the Company's primary listing on the Toronto Stock Exchange (TSX: ACB). Aurora shareholders DO NOT need to take any further
Transfering the listing to the Nasdaq is part of Aurora's
recently announced cost efficiency initiatives and aligns the Company with other cannabis peers on an exchange known for innovative and
growth-oriented companies.
The last day of trading of the Company's common stock
on NYSE was May 24, 2021.
Aurora is a global leader in the cannabis industry
serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to
helping people improve their lives. The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie,
MedReleaf, CanniMed, Whistler, and Reliva CBD. Providing customers with innovative, high-quality cannabis products, Aurora's brands continue
to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched. For more
information, please visit our website at www.auroramj.com.
Aurora's common shares trade on the TSX and NASDAQ
under the symbol "ACB", and is a constituent of the S&P/TSX Composite Index.
Forward Looking Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan", "continue", "expect", "project",
"intend", "believe", "anticipate", "estimate", "may", "will", "potential",
"proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur.
These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections
contained in the forward-looking statements throughout this news release. Forward looking statements are based on the opinions, estimates
and assumptions of management in light of management's experience and perception of historical trends, current conditions and expected
developments at the date the statements are made, such as current and future market conditions, the ability to maintain SG&A costs
in line with current expectations, the ability to achieve high margin revenues in the Canadian consumer market, the current and future
regulatory environment and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and
other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of
activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements,
including the risks associated with: entering the U.S. market, the ability to realize the anticipated benefits associated with the acquisition
of Reliva, achievement of Aurora's business transformation plan, general business and economic conditions, changes in laws and regulations,
product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other
risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information form dated September
24, 2020 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com and
filed with and available on the SEC's website at www.edgar.gov. The Company cautions that the list of risks, uncertainties and other factors
described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks,
uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on
such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities
View original content to download multimedia:http://www.prnewswire.com/news-releases/aurora-cannabis-to-begin-trading-on-the-the-nasdaq-global-select-market-on-may-25-2021-at-market-open-301297980.html
SOURCE Aurora Cannabis Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2021/24/c8684.html
For further information: For Media: Michelle Lefler, VP, Communications
& PR, media@auroramj.com; For Investors: ICR, Inc, Investor Relations, aurora@icrinc.com
CO: Aurora Cannabis Inc.
CNW 17:00e 24-MAY-21